|
1,976
|
| 15485 |
MAS1
|
|
affects_activity of
|
ACE2
|
|
|
20660625
|
Diabetes mellitus, type II
Insulin resistance
|
|
2,002
|
| 15889 |
A-779
|
|
decreases_activity of
|
MAS1
|
|
|
20808802
|
Diabetes mellitus, type II
Insulin resistance
|
|
6,741
|
| 65314 |
DLG4
|
|
increases_activity of
|
MAS1
|
|
| 65315 |
DLG4
|
|
interacts (colocalizes) with
|
MAS1
|
|
|
23701246
|
Diabetes mellitus, type II
Coronary artery disease
Insulin resistance
|
|
11,717
|
| 116374 |
Angiotensin (1-7)
|
|
affects_activity of
|
MAS1
|
|
|
30404071
|
Diabetes mellitus, type II
Insulin resistance
|
|
11,748
|
| 116373 |
Angiotensin (1-7)
|
|
increases_activity of
|
MAS1
|
|
|
32333398
|
COVID-19
|
|
11,776
|
| 116592 |
Angiotensin (1-7)
|
|
increases_activity of
|
MAS1
|
|
| 116595 |
MAS1
|
|
increases_activity of
|
arachidonic acid secretion
|
|
| 116597 |
MAS1
|
|
increases_phosphorylation of
|
AKT1
|
|
| 116615 |
MAS1
|
|
affects_activity of
|
cardiac fibrosis
|
|
| 116616 |
MAS1
|
|
decreases_activity of
|
heart failure
|
|
| 116617 |
MAS1
|
|
affects_activity of
|
abnormal circulating lipid level
|
|
| 116619 |
MAS1
|
|
affects_activity of
|
impaired glucose tolerance
|
|
| 116620 |
MAS1
|
|
affects_activity of
|
Insulin resistance
|
|
| 116621 |
MAS1
|
|
affects_activity of
|
increased circulating insulin level
|
|
| 116622 |
MAS1
|
|
affects_activity of
|
glucose import
|
in white adipose tissue
|
|
23463883
|
Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
|
|
11,777
|
| 116631 |
embryo development
|
|
affects_expression of
|
MAS1
|
|
|
26029927
|
Diabetes mellitus, type II
Insulin resistance
|
|
11,821
|
| 116759 |
Angiotensin (1-7)
|
|
increases_activity of
|
MAS1
|
|
| 116760 |
MAS1
|
|
decreases_activity of
|
AGTR1
|
|
|
32341442
|
COVID-19
|
|
11,918
|
| 117242 |
Angiotensin (1-5)
|
|
increases_activity of
|
MAS1
|
in atrium
|
|
27660028
|
Cardiovascular disease
|
|
11,922
|
| 117257 |
Angiotensin (1-7)
|
|
increases_activity of
|
MAS1
|
in LPS plus IFNG-stimulated macrophages
|
| 117275 |
MAS1
|
|
decreases_expression of
|
IL1B
|
in LPS plus IFNG-stimulated macrophages
|
| 117276 |
MAS1
|
|
decreases_expression of
|
CCL2
|
in LPS plus IFNG-stimulated macrophages
|
| 117277 |
MAS1
|
|
decreases_expression of
|
TNF
|
in LPS plus IFNG-stimulated macrophages
|
| 117282 |
MAS1
|
|
decreases_activity of
|
inflammatory response
|
in LPS plus IFNG-stimulated macrophages
|
|
30918468
|
Lung disease
|
|
11,928
|
| 117302 |
Angiotensin (1-7)
|
|
increases_activity of
|
MAS1
|
in HEK293 cells
|
|
27217404
|
Cardiovascular disease
|
|
11,934
|
| 117316 |
MAS1
|
|
interacts (colocalizes) with
|
AGTR1
|
|
| 117329 |
MAS1
|
|
decreases_activity of
|
AGTR1
|
|
| 117330 |
Angiotensin II
|
NOT |
increases_activity of
|
MAS1
|
|
| 117331 |
MAS1
|
|
affects_activity of
|
inositol phosphate biosynthetic process
|
|
| 117332 |
MAS1
|
|
affects_activity of
|
calcium ion homeostasis
|
|
| 117333 |
MAS1
|
|
is_part_of
|
AGTR1-MAS1 complex
|
in HEK293 cells
|
|
15809376
|
Cardiovascular disease
|
|
11,935
|
| 117317 |
Angiotensin (1-7)
|
NOT |
interacts (colocalizes) with
|
MAS1
|
|
|
29928987
|
Cardiovascular disease
|
|
11,936
|
| 117318 |
Angiotensin (1-7)
|
|
increases_activity of
|
MAS1
|
in kidney
|
| 117361 |
MAS1
|
|
increases_activity of
|
vasodilation
|
in aorta
|
|
12829792
|
Cardiovascular disease
|
|
11,937
|
| 117319 |
MAS1
|
|
interacts (colocalizes) with
|
AGTR2
|
|
| 117362 |
MAS1
|
|
is_part_of
|
AGTR2-MAS1 complex
|
in astrocytes
|
|
28461604
|
Cardiovascular disease
|
|
12,017
|
| 117744 |
Angiotensin (1-9)
|
NOT |
increases_activity of
|
MAS1
|
|
|
29962859
|
Cardiovascular disease
|
|
12,029
|
| 118020 |
Angiotensin (1-7)
|
|
increases_activity of
|
MAS1
|
|
| 118023 |
Angiotensin (1-7)
|
NOT |
increases_activity of
|
MAS1
|
in mammary arteries, in splanchnic vessel, in aorta
|
| 118024 |
Neuropeptide FF
|
|
increases_activity of
|
MAS1
|
|
| 118025 |
Alamandine
|
|
increases_activity of
|
MAS1
|
|
| 118026 |
Angiotensin III
|
|
increases_activity of
|
MAS1
|
|
| 118027 |
Angiotensin IV
|
|
increases_activity of
|
MAS1
|
|
| 118028 |
Angioprotectin
|
|
increases_activity of
|
MAS1
|
|
| 118049 |
MAS1
|
|
increases_activity of
|
insulin receptor signaling pathway
|
|
|
30934934
|
Diabetes mellitus, type II
Insulin resistance
Cardiovascular disease
|
|
12,034
|
| 118072 |
MAS1
|
|
interacts (colocalizes) with
|
AGTR1
|
in alveolar epithelial
cells, in alveolar macrophages
|
|
22009550
|
Lung disease
|
|
12,056
|
| 118271 |
Angiotensin (1-7)
|
|
interacts (colocalizes) with
|
MAS1
|
|
| 118314 |
Angiotensin (1-7)
|
|
increases_activity of
|
MAS1
|
|
| 118318 |
MAS1
|
|
decreases_activity of
|
AGTR1
|
|
|
19065996
|
Diabetes mellitus, type II
Insulin resistance
|
|
12,064
|
| 118372 |
MAS1
|
|
is_expressed_in
|
endothelium
|
|
| 118419 |
MAS1
|
|
affects_activity of
|
abnormal circulating lipid level
|
|
| 118420 |
MAS1
|
|
affects_activity of
|
increased circulating insulin level
|
|
| 118421 |
MAS1
|
|
affects_activity of
|
abnormal circulating leptin level
|
|
| 118422 |
MAS1
|
|
affects_activity of
|
increased abdominal adipose tissue amount
|
|
| 118423 |
MAS1
|
|
affects_activity of
|
impaired glucose tolerance
|
|
| 118424 |
MAS1
|
|
affects_activity of
|
decreased insulin sensitivity
|
|
| 118425 |
MAS1
|
|
affects_activity of
|
glucose import
|
into adipocytes; if stimulated by insulin
|
| 118426 |
MAS1
|
|
affects_quantity of
|
SLC2A4
|
in adipocytes
|
|
19065996
|
Diabetes mellitus, type II
Insulin resistance
|
|
12,082
|
| 118672 |
Angiotensin (1-7)
|
|
increases_activity of
|
MAS1
|
|
| 118673 |
MAS1
|
|
decreases_activity of
|
inflammatory response
|
|
| 118674 |
MAS1
|
|
decreases_activity of
|
response to oxidative stress
|
|
| 118675 |
MAS1
|
|
increases_activity of
|
vasodilation
|
|
|
32348783
|
Cardiovascular disease
COVID-19
|
|
12,098
|
| 118800 |
MAS1
|
|
is_expressed_in
|
blood platelet
|
|
| 118802 |
Angiotensin (1-7)
|
|
interacts (colocalizes) with
|
MAS1
|
in blood platelets
|
|
18026570
|
Cardiovascular disease
|
|
12,099
|
| 118801 |
Angiotensin (1-7)
|
|
interacts (colocalizes) with
|
MAS1
|
in blood platelets
|
| 118805 |
MAS1
|
|
increases_quantity of
|
NO
|
in blood platelets
|
| 119560 |
MAS1
|
|
decreases_activity of
|
thrombosis
|
|
|
18026570
|
Cardiovascular disease
|
|
12,183
|
| 119485 |
MAS1
|
|
decreases_activity of
|
fibrosis
|
in lung
|
| 119500 |
MAS1
|
|
decreases_activity of
|
cardiac interstitial fibrosis
|
|
| 119510 |
MAS1
|
|
decreases_activity of
|
response to oxidative stress
|
in pulmonary artery, in lung
|
|
20581171
|
Lung disease
|
|
12,330
|
| 120871 |
Angiotensin (1-7)
|
|
increases_activity of
|
MAS1
|
|
| 120872 |
MAS1
|
|
decreases_activity of
|
Insulin resistance
|
|
|
23893738
|
Diabetes mellitus, type II
Insulin resistance
|
|
12,337
|
| 120769 |
Aldosterone
|
|
decreases_expression of
|
MAS1
|
|
| 120775 |
Spironolactone
|
|
decreases_quantity of
|
MAS1
|
|
|
31165585
|
Chronic kidney disease
|
|
12,362
|
| 121130 |
MAS1
|
|
increases_activity of
|
Phosphatidylinositol 3-kinase
|
in adipocytes
|
| 121157 |
MAS1
|
|
increases_activity of
|
glucose import
|
|
| 121209 |
MAS1
|
|
affects_activity of
|
glucose homeostasis
|
|
| 121210 |
MAS1
|
|
affects_activity of
|
lipid homeostasis
|
|
| 121211 |
MAS1
|
|
affects_activity of
|
increased circulating insulin level
|
|
| 121212 |
MAS1
|
|
affects_quantity of
|
LEP
|
|
| 121213 |
MAS1
|
|
affects_quantity of
|
abdominal adipose tissue
|
|
| 121214 |
MAS1
|
|
affects_expression of
|
SLC2A4
|
in adipose tissue
|
| 121215 |
MAS1
|
|
affects_expression of
|
PPARG
|
in adipose tissue
|
|
24450744
|
Diabetes mellitus, type II
Insulin resistance
|
|
13,516
|
| 127465 |
MAS1
|
|
decreases_activity of
|
ERBB2
|
in aortic smooth muscle cells
|
|
26536590
|
Diabetes mellitus, type II
Insulin resistance
|
|
13,667
|
| 128386 |
GHR
|
|
affects_quantity of
|
MAS1
|
in heart, in kidney
|
|
22947377
|
Cardiovascular disease
|
|
13,891
|
| 131222 |
Dopamine
|
|
increases_expression of
|
MAS1
|
in kidney
|
|
21701066
|
Renal
|
CIDeRplus